A controversial Philadelphia ordinance that would have required sales reps to become licensed, prevented drug makers from giving gifts to doctors, and prohibited distribution of copay coupons for controlled substances was voted down amid lobbying by restaurants and pharmaceutical companies.

The ordinance, which was designed to blunt the effects of the opioid crisis, was defeated even after it was amended to pertain only to companies selling prescription drugs that are addictive, but not every drug manufacturer (more here). The final vote was 9 to 5, with two abstentions.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy